Skip to main content

Pharmacotherapy of Personality Disorders

  • Chapter
  • 276 Accesses

Abstract

While the major pathogenic theory of personality disorders held by American psychiatrists is psychoanalytic (Abraham, 1949; Reich, 1949; Knight, 1953; Kernberg, 1975), the biological approach to personality disorders has an equally lengthy history. The modern era began with Kraepelin (1921), who observed affective temperaments in the premorbid history of many manic depressives and their non-ill biological relatives. Later investigators, such as Kretschmer (1936) and Schneider (1959) described constitutional factors thought to underlie both normal and deviant personality types. The major thrust of these studies was the notion that diluted versions of major schizophrenic, affective, and organic disorders could express themselves as chronic, maladaptive patterns of experiencing and functioning in the world; that is, personality disorders. With the modern tools of psychopharmacology, psychobiology, family studies, and clinical studies, these theories can be better tested.

Keywords

  • Personality Disorder
  • Panic Attack
  • Antisocial Personality Disorder
  • Borderline Personality Disorder
  • Attention Deficit Disorder

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-4757-1987-1_4
  • Chapter length: 18 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   89.00
Price excludes VAT (USA)
  • ISBN: 978-1-4757-1987-1
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   119.99
Price excludes VAT (USA)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abraham K., 1949, Selected Papers on Psychoananlysis ( 1921–1925 ), London, Hogarth Press.

    Google Scholar 

  • Akiskal H.S., 1981, Subaffective disorders: Dysthymic, cyclothymic and bipolar II disorders in the “borderline” realm. Psychiatr. Clin. North Am. 4: 26–46.

    Google Scholar 

  • Akiskal H.S., 1979, Khani M.K., Scott-Straus A: Cyclothymic temperamental disorders. Psychiatr. Clin. North Am. 2: 527–554.

    Google Scholar 

  • Andrulonis P.A., Donnelly J., Glueck B.C. et al: 1980, Preliminary data on ethosuximide and the episodic dyscontrol syndrome. Am. J. Psychiatry 137: 1455–1456.

    PubMed  CAS  Google Scholar 

  • Aono T., Kaneko M., Numata Y., et al: 1981, Effects of amoxapine, a new antidepressant, on psuedoneurotic schizophrenia. Folia Psychiatr.Neurol. Japan, 35: 115–121.

    CAS  Google Scholar 

  • Bach-Y-Rita G., Lion J.R., Climent C.E., et al: 1971, Episodic dyscontrol: A study of 130 violent patients. Am.J.Psychiatry 127: 1473–1478.

    PubMed  CAS  Google Scholar 

  • Barnes R.J: 1977, Mesoridazine (Serenitil) in personality disorders–a controlled trial in adolescent patients. Diseases of the Nervous System 38: 258–264.

    PubMed  CAS  Google Scholar 

  • Baxter L., Edell W., Gerner R., et al: 1984, Dexamethasone suppression test and Axis I diagnosis of in-patients with DSM-III borderline personality disorder. J. Clin. Psychiatry 45: 150–153.

    PubMed  CAS  Google Scholar 

  • Brinkley J.R., Beitman B.D., Friedel R.O.: 1979, Low-dose neuroleptic regimensin the treatment of borderline patients.Arch Gen Psychiatry 36: 319–326.

    CrossRef  CAS  Google Scholar 

  • Brown G.L. and Goodwin F.K.: 1986, Human aggression: A biological perspective in Unmasking The Psychopath: Antisocial Personality and Related Syndromes. Edited by Reid W.M., Dorr D., Waller JI. et al. W.W. Norton, N.Y.

    Google Scholar 

  • Carroll B.J., Greden J.F., Feinberg M., et al: 1981, Neuroendocrine evaluation of depression in borderline patients. Psychiatr. Clin. North Am. 4: 89–98.

    CAS  Google Scholar 

  • Chodoff P.: 1974, Diagnosis of hysteria - an overview. Am. J. Psychiatry 131:1073–1078.

    Google Scholar 

  • Elliot F.A.: 1977, Propranolol for the control of belligerent behavior following acute brain damage. Ann. Neurol 1: 489–491.

    CrossRef  Google Scholar 

  • Faltus F.J.: 1984, The positive effect of alprazolam in the treatment of three patients with borderline personality disorder Am. J. Psychiatry 141: 802–803.

    PubMed  CAS  Google Scholar 

  • Feighner J.P., Herbstein J., Damlouji N.:1985, Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. J.Clin.Psychiatry 46: 206–209

    PubMed  CAS  Google Scholar 

  • Garbutt J.C., Loosen P.T., Tipermas A., et al: 1983, The TRH test in patients with borderline personality disorder. Psychiatry Res. 9: 107–113.

    PubMed  CrossRef  CAS  Google Scholar 

  • Gardner D.L., Cowdry R.W.: 1985, Alprazolam–induced dyscontrol in borderline personality disorder. Am. J Psychiatry 142: 98–100.

    PubMed  CAS  Google Scholar 

  • Goldberg S.C., Schulz S.C., Schulz P.M. et al: 1986, Borderline and schizotypal personality disorders treated with low dose thothixene vs. placebo. Arch. Gen. Psychiatry, 43: 680–686.

    PubMed  CrossRef  CAS  Google Scholar 

  • Gunderson J.: 1984, Borderline Personality Disorder. Washington DC, American Psychiatric Press, Inc.

    Google Scholar 

  • Hedberg D.L., Houck J.H., Glueck B.C.: 1971, Tranylcypromine–trifluoerazine combination in the treatment of schizophrenia. Am. J. Psychiatry 127: 1141–1146.

    PubMed  CAS  Google Scholar 

  • Hymowitz P., Frances A.J., Hoyt R., et al: 1984, Neuroleptic Treatment of Schizotypal Personalities. Presented at the 137th Annual Meeting of the American Psychiatric Association, Los Angeles.

    Google Scholar 

  • Kernberg O.F.: 1975, Borderline Conditions and Pathological Narcissim. New York, Jason Aronson Inc.

    Google Scholar 

  • Kety S.S., Rosenthal D., Wender P.H., et al: 1968, The types and prevalence of mental illness in the biological and adoptive familes of adoptive schizophrenics, in The Transmission of Schizophrenia, ed. Rosenthal D., Kety S.S., Oxford Pergamon Press.

    Google Scholar 

  • Klein D.F.:1964, Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5:397–408.

    PubMed  CrossRef  CAS  Google Scholar 

  • Klein D.F.: 1967, Importance of psychiatric diagnosis in the prediction of clinical drug effects. Arch. Gen. Psychiatry 16: 118–126.

    PubMed  CrossRef  CAS  Google Scholar 

  • Klein D.F.: 1975, Psychopharmacology and the borderline patient, in Borderline States in Psychiatry. Edited by Mack JE, New Yor, Grune & Stratton

    Google Scholar 

  • Knight R.P.: 1953, Borderline states. Bull. Menningner Clin. 17: 1–11.

    Google Scholar 

  • Kraepelin E.: 1921, Manic Depressive Insanity and Paranoia. Edinburgh, E & S Livingston.

    Google Scholar 

  • Kretschmer E.: 1936, Physique and Character, 2nd edition. London, Routledge.

    Google Scholar 

  • Leone N.F.: 1982, Response of borderline patients to loxapine and chlorpromazine. J. Clin. Psychiatry 43: 148–150.

    PubMed  CAS  Google Scholar 

  • Liebowitz J.H., Rudy V., Gershon E.S., et al: 1976, A pharmacogenetic case report: Lithium -responsiveness postpsychotic antisocial behavior. Compr.Psychiatry 17: 655–660.

    PubMed  CrossRef  CAS  Google Scholar 

  • Liebowitz M.R.: 1979, Is borderline a distinct entity? Schizophr. Bull. 5: 23–38.

    PubMed  CrossRef  CAS  Google Scholar 

  • Liebowitz M.R., Klein D.F.: 1979, Hysteroid dysphoria. Psychiatr. Clin. North Am. 2: 555–575.

    Google Scholar 

  • Liebowitz M.R, Klein D.F.: 1981, Interrelationship of hysteroid dysphoria and borderline personality disorder. Psychiatr. Clin.North Am. 4: 67–87.

    CAS  Google Scholar 

  • Liebowitz M.R., Quitkin F.M., Stewart J.W., et al: 1984, Phenelzine vs. imipramine in atypical depression:A preliminary report.Arch. Gen. Psychiatry 41: 669–677.

    CrossRef  CAS  Google Scholar 

  • Liebowitz M.R., Gorman J.M., Fyer A.J., et al: Social phobia: 1985, Review of a neglected anxiety disorder. Arch. Gen. Psychiatry 42: 729–736.

    CrossRef  Google Scholar 

  • Liebowitz M.R., Fyer A.J., Gorman J.M., et al: 1986, Phenelzine in social phobia. J. Clinic. Psychopharmacol. 6: 93–98.

    CAS  Google Scholar 

  • Liebowitz M.R., et al: Obsessive compulsive disorder: Paradigmatic shift and an improved prognosis (submitted for publication)

    Google Scholar 

  • McNamara E., Reynolds C.F., Soloff P.H., et al: 1984, EEG sleep evaluation of depression in borderline patients. Am. J. Psychiatry 141: 182–186.

    PubMed  CAS  Google Scholar 

  • Millon T.: 1969, Modern Psychopathology: A Biosocial Approach to Maladaptive Learning and Functioning. Philadelphia, WB Saunders.

    Google Scholar 

  • Nies A., Howard D., Robinson D.S.: 1982, Antianxiety effects of MAO inhibitors, in The Biology of Anxiety, ed. Mathew RJ. New York, Brunner/Mazel.

    Google Scholar 

  • Quitkin F., Rifkin A., Klein D.F.: 1976, Neurologic soft signs in schizophrenia and character disorders: Organicity in schizophrenia with premorbid asociality and emotionally unstable character disorders. Arch. Gen. Psychiatry 33: 845–853.

    PubMed  CrossRef  CAS  Google Scholar 

  • Ratey J.J., Morrill R., Oxenkrug F:. 1983, Use of propranolol for provoked and unprovoked episodes of rage, Am. J.Psychiatry 140: 1356–1357.

    PubMed  CAS  Google Scholar 

  • Reich W.:1949, Character Analysis, New York, Noonday Press.

    Google Scholar 

  • Reyntjens A.M.: 1972, A series of multicentric pilot trials with pimozide in psychiatric practice, I: Pimozide in the treatment of personality disorders. Acta. Psychiatr. Belg. 72: 653–661.

    PubMed  CAS  Google Scholar 

  • Rifkin A., Quitkin F., Carrillo C., et al: 1972, Lithium carbonate in emotionally unstable character disorder. Arch. Gen.Psychiatry 27: 519–523.

    PubMed  CrossRef  CAS  Google Scholar 

  • Rosenbaum J.F.,Woods S.W., Groves J.E., et al: 1984, Emergence of hostility during alprazolam treatment. Am. J. Psychiatry 141: 792–793.

    PubMed  CAS  Google Scholar 

  • Rosenthal D., Wender P.H. Kety S.S., et al: 1968, Schizophrenics’ offspring reared in adoptive homes, in The Transmission of Schizophrenia, ed. Rosenthal D, Kety S, Oxford, Pergamon Press.

    Google Scholar 

  • Schatzberg A.F., Cole J.O.: 1981, Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders. Br. J. Clin. Pharmacol. 11: 175–225.

    Google Scholar 

  • Schneider K.: 1959, Clinical Psychopathology. New York, Grune & Stratton. Serban G.: 1984, Borderline and schizotypal personality disorders: Criteria for diagnosis and treatment. Am. J.Psychiatry 141: 1455–1458.

    Google Scholar 

  • Sheard M.H., Marini J.L., Bridges D.I., et al: 1976, The effect of lithium on impulsive aggressive behavior in man. Am. J. Psychiatry 133: 1409–1413.

    PubMed  CAS  Google Scholar 

  • Sheehan D.V., Coleman J.H., Greenblatt D.J., et al: 1984, Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. Clin.Psychopharmacol. 4: 66–75.

    CrossRef  CAS  Google Scholar 

  • Soloff P.H., George A., Nathan R.S,. et al:1986a, Progress in pharmacotherapy of borderline disorders. Arch. Gen. Psychiatry 43: 691–697.

    PubMed  CrossRef  CAS  Google Scholar 

  • Soloff P.H., George A., Nathan R.S,. et al: 1986b, Paradoxical effect of amitriptyline on borderline patients. Am. J. Psychiatry 143: 1603–1605.

    PubMed  CAS  Google Scholar 

  • Stringer AY, Joseph NC: 1983, Methylphenidate in the treatment of aggression in two patients with antisocial personality disorder. Am. J. Psychiatry 140: 1365–1366.

    PubMed  CAS  Google Scholar 

  • Stone M.H.: 1979, Contemporary shift of the borderline concept from a subschizophrenic disorder to a subaffectve disorder.Psychiatr. Clin. North Am. 2: 577–594.

    Google Scholar 

  • Thoren J.P., Asberg M., Cronholm B., et al: 1973, Clomipramine treatment of obsessive -compulsive disorder. Arch. Gen. Psychiatry 37: 311–317.

    Google Scholar 

  • Tupin J.P. Smith D.B., Clanon T.I., et al: 1973, The long-term use of lithium in aggressive prisoners. Compr. Psychiatry 14: 311–317.

    PubMed  CrossRef  CAS  Google Scholar 

  • Turnquist K., Frances R., Rosenfeld W., et al: 1983, Pemoline in attention deficit disorder and alcoholism: A case study. Am. J. Psychiatry 140: 622–624.

    PubMed  CAS  Google Scholar 

  • Wender P.H., Reimherr F.W., Wood D.R.: 1981, Attention deficit disorder (minimal brain dysfunction) in adults. Arch. Gen. Psychiatry 38: 449–456.

    PubMed  CrossRef  CAS  Google Scholar 

  • Wood D..R., Reimherr F.W., Wender P.H., et al:1976, Diagnosis and treatment of minimal brain dysfunction in adults. Arch. Gen. Psychiatry 33: 1453–1460.

    PubMed  CrossRef  CAS  Google Scholar 

  • Yerevanian B.I., Akiskal H.S.: 1979, “Neurotic,” characterological, and dysthymic depressions. Psychiatr. Clin. North Am. 2:595–617.

    Google Scholar 

  • Yudofsky S., Williams D., Gorman J.M.: 1981, Propranolol in treatment of rage and violent behavior in patients with chronic brain syndrome. Am.J. Psychiatry 138: 218–220.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 1988 Springer Science+Business Media New York

About this chapter

Cite this chapter

Liebowitz, M.R. (1988). Pharmacotherapy of Personality Disorders. In: Clynes, M., Panksepp, J. (eds) Emotions and Psychopathology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1987-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1987-1_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1989-5

  • Online ISBN: 978-1-4757-1987-1

  • eBook Packages: Springer Book Archive